Anaplastic Cancer and Rare Forms of Cancer Affecting the Thyroid

  • Brian R. UntchEmail author
  • John A. OlsonJr.


This chapter will focus on anaplastic thyroid carcinoma (ATC), thyroid lymphoma, and metastases to the thyroid gland from non-thyroid cancers. Although these entities represent three uncommon clinical scenarios, thyroid physicians should be knowledgeable on how to manage each. ATC is a highly lethal disease with survival usually measured in months. Management should be focused on diagnosis, appropriate counseling, and supportive care, and when possible, clinical trial enrollment. Thyroid lymphoma, most commonly diffuse large B-cell lymphoma (DLBCL), is not typically treated with thyroidectomy, but patients often present to the surgeon for initial management and biopsy. Lastly, metastatic disease that has spread to the thyroid gland has a number of important considerations, most notably that patients undergoing thyroid metastasectomy should be highly selected and offered resection only after multidisciplinary evaluation.


Anaplastic thyroid cancer Tracheostomy Thyroid lymphoma Metastasis to the thyroid Diffuse large b-cell lymphoma 


  1. 1.
    Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A national cancer data base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985–1995 [see comments]. Cancer. 1998;83:2638–48.CrossRefPubMedGoogle Scholar
  2. 2.
    Kitamura Y, Shimizu K, Nagahama M, Sugino K, Ozaki O, Mimura T, Ito K, Ito K, Tanaka S. Immediate causes of death in thyroid carcinoma: clinicopathological analysis of 161 fatal cases. J Clin Endocrinol Metab. 1999;84:4043–9.CrossRefPubMedGoogle Scholar
  3. 3.
    Smallridge RC, Marlow LA, Copland JA. Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies. Endocr Relat Cancer. 2009;16:17–44.PubMedCentralCrossRefPubMedGoogle Scholar
  4. 4.
    Kebebew E, Greenspan FS, Clark OH, Woeber KA, McMillan A. Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors. Cancer. 2005;103:1330–5.CrossRefPubMedGoogle Scholar
  5. 5.
    Cancer Genome Atlas Research N. Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014;159:676–90.CrossRefGoogle Scholar
  6. 6.
    Landa I, Ganly I, Chan TA, Mitsutake N, Matsuse M, Ibrahimpasic T, Ghossein RA, Fagin JA. Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease. J Clin Endocrinol Metab. 2013;98:E1562–6.PubMedCentralCrossRefPubMedGoogle Scholar
  7. 7.
    Smallridge RC, Ain KB, Asa SL, Bible KC, Brierley JD, Burman KD, Kebebew E, Lee NY, Nikiforov YE, Rosenthal MS, Shah MH, Shaha AR, Tuttle RM, American Thyroid Association Anaplastic Thyroid Cancer Guidelines T. American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid. 2012;22:1104–39.CrossRefPubMedGoogle Scholar
  8. 8.
    Mohebati A, Dilorenzo M, Palmer F, Patel SG, Pfister D, Lee N, Tuttle RM, Shaha AR, Shah JP, Ganly I. Anaplastic thyroid carcinoma: a 25-year single-institution experience. Ann Surg Oncol. 2014;21:1665–70.CrossRefPubMedGoogle Scholar
  9. 9.
    Sherman EJ, Lim SH, Ho AL, Ghossein RA, Fury MG, Shaha AR, Rivera M, Lin O, Wolden S, Lee NY, Pfister DG. Concurrent doxorubicin and radiotherapy for anaplastic thyroid cancer: a critical re-evaluation including uniform pathologic review. Radiother Oncol. 2011;101:425–30.CrossRefPubMedGoogle Scholar
  10. 10.
    Haymart MR, Banerjee M, Yin H, Worden F, Griggs JJ. Marginal treatment benefit in anaplastic thyroid cancer. Cancer. 2013;119:3133–9.PubMedCentralCrossRefPubMedGoogle Scholar
  11. 11.
    Walsh S, Lowery AJ, Evoy D, McDermott EW, Prichard RS. Thyroid lymphoma: recent advances in diagnosis and optimal management strategies. Oncologist. 2013;18:994–1003.PubMedCentralCrossRefPubMedGoogle Scholar
  12. 12.
    Holm LE, Blomgren H, Lowhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med. 1985;312:601–4.CrossRefPubMedGoogle Scholar
  13. 13.
    Derringer GA, Thompson LD, Frommelt RA, Bijwaard KE, Heffess CS, Abbondanzo SL. Malignant lymphoma of the thyroid gland: a clinicopathologic study of 108 cases. Am J Surg Pathol. 2000;24:623–39.CrossRefPubMedGoogle Scholar
  14. 14.
    Graff-Baker A, Roman SA, Thomas DC, Udelsman R, Sosa JA. Prognosis of primary thyroid lymphoma: demographic, clinical, and pathologic predictors of survival in 1,408 cases. Surgery. 2009;146:1105–15.CrossRefPubMedGoogle Scholar
  15. 15.
    Isaacson PG. Mucosa-associated lymphoid tissue lymphoma. Semin Hematol. 1999;36:139–47.PubMedGoogle Scholar
  16. 16.
    Pyke CM, Grant CS, Habermann TM, Kurtin PJ, van Heerden JA, Bergstralh EJ, Kunselman A, Hay ID. Non-Hodgkin’s lymphoma of the thyroid: is more than biopsy necessary? World J Surg. 1992;16:604–9. Discussion 609–610.CrossRefPubMedGoogle Scholar
  17. 17.
    Ha CS, Shadle KM, Medeiros LJ, Wilder RB, Hess MA, Cabanillas F, Cox JD. Localized non-Hodgkin lymphoma involving the thyroid gland. Cancer. 2001;91:629–35.CrossRefPubMedGoogle Scholar
  18. 18.
    Hull OH. Critical analysis of two hundred twenty-one thyroid glands; study of thyroid glands obtained at necropsy in Colorado. AMA Arch Pathol. 1955;59:291–311.PubMedGoogle Scholar
  19. 19.
    Nixon IJ, Whitcher M, Glick J, Palmer FL, Shaha AR, Shah JP, Patel SG, Ganly I. Surgical management of metastases to the thyroid gland. Ann Surg Oncol. 2011;18:800–4.CrossRefPubMedGoogle Scholar
  20. 20.
    Katz SC, Shaha A. PET-associated incidental neoplasms of the thyroid. J Am Coll Surg. 2008;207:259–64.CrossRefPubMedGoogle Scholar
  21. 21.
    Untch BR, Olson JA, Jr. Anaplastic thyroid carcinoma, thyroid lymphoma, and metastasis to thyroid. Surg Oncol Clin N Am. 2006;15:661–79, x.Google Scholar
  22. 22.
    Tanvetyanon T, Robinson LA, Schell MJ, Strong VE, Kapoor R, Coit DG, Bepler G. Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis. J Clin Oncol. 2008;26:1142–7.CrossRefPubMedGoogle Scholar
  23. 23.
    Montero PH, Ibrahimpasic T, Nixon IJ, Shaha AR. Thyroid metastasectomy. J Surg Oncol. 2014;109:36–41.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Department of Surgery, Gastric and Mixed Tumor ServiceMemorial Sloan Kettering Cancer CenterNew YorkUSA
  2. 2.Department of Surgery, Head and Neck ServiceMemorial Sloan Kettering Cancer CenterNew YorkUSA
  3. 3.Department of SurgeryUniversity of MarylandCollege ParkUSA

Personalised recommendations